effect of zinc on diabetes

The effect of oral Zinc Supplementation on Glycemic Control in Type 2 Diabetic patients: a single blind randomised controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202005906229512

Enrollment

200

Registered

2020-05-13

Start date

2017-12-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

zinc sulphate

placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with type 2 diabetes, aged >18 years old, attending the clinic for a routine follow-up visit, on regular use of oral anti-diabetic drugs, with HbAlc concentrations of 7.5-9.5%, who were not enrolled in similar program in the last 6 months, and not taking vitamins or mineral supplements in previous 2 months.

Exclusion criteria

Exclusion criteria: severe or uncontrolled cardiovascular disease (defined as a cardiovascular event within the last year), psychiatric disease or cognitive impairment interfering with treatment compliance, pregnancy or lactating women.

Design outcomes

Primary

Measure	Time frame
glycated hemoglobin HbA1c	—

Secondary

Measure	Time frame
body mass index	—

Countries

Egypt

Contacts

Public Contactalmass hassan

lecturer

almass.fathi@yahoo.com0201229350414

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026